• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,237.99 -160.73
( -0.21%)
Global Indices
Nasdaq
49,543.85 -540.61
(-1.08%)
Dow Jones
7,428.26 -93.98
(-1.25%)
Hang Seng
61,141.50 -1,512.55
(-2.41%)
Nikkei 225
10,172.40 -200.53
(-1.93%)
Forex
USD-INR
95.71 0.07
(0.07%)
EUR-INR
111.93 -0.13
(-0.12%)
GBP-INR
129.01 -0.31
(-0.24%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
578.2640535
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
69.77
179485.96
EPS(TTM)
Face Value()
Div & Yield %
96.91
2
0.44
 

simplex papers ltd
Gammon India reports consolidated net loss of Rs 317.47 crore in the September 2025 quarter
Dec 11,2025
Net Loss of Gammon India reported to Rs 317.47 crore in the quarter ended September 2025 as against net loss of Rs 173.49 crore during the previous quarter ended September 2024. Sales rose 54.40% to Rs 10.87 crore in the quarter ended September 2025 as against Rs 7.04 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales10.877.04 54
OPM %41.03437.93 -
PBDT-316.38-173.00 -83
PBT-316.79-173.52 -83
NP-317.47-173.49 -83